Chudova Darya's Form 4 filing
Guardant Health, Inc. (GH) · filed Dec 10, 2025
- Accession no.
- 0001977179-25-000008
- Filed
- Dec 10, 2025
- Trade date
- Dec 8, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $2.42M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chudova DaryaCIK 0001977179 | Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Common Stock | JOtherDisposed | −68,144 | $0.00 | $0 | 21,734 | Direct | |
| Dec 8, 2025 | Common Stock | JOtherAcquired | +68,144 | $0.00 | $0 | 68,144 | Indirect | |
| Dec 8, 2025 | Common Stock | SSaleDisposed | −9,271 | $106.00F2 | −$982,726 | 12,463 | Direct | |
| Dec 8, 2025 | Common Stock | SSaleDisposed | −13,664 | $105.04F3 | −$1,435,266.56 | 54,480 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.11. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.24. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
Remarks
Table I includes 488 shares acquired under the Guardant Health's Employee Stock Purchase Plan on 5/14/2023.